Accelerating COVID-19 Therapeutic Interventions and Vaccines, The ACTIV-1 Immune Modulator (IM); Immune Modulators for Treating COVID-19 (ACTIV-1 IM)
From Clinicaltrials.gov: "ACTIV-1 IM is a master protocol designed to evaluate multiple investigational agents for the treatment of moderately or severely ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The research objectives are to evaluate each agent with respect to speed of recovery, mortality, illness severity, and hospital resource utilization."
Acronym: ACTIV-1 IM
Clinical Centers: 85
Participants: 1,971
Beginning:
Ending:
Funding: US Department of Health and Human Services
Study Design: Interventional